Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer, Secondary cancers
Closed
Phase 3
This trial is comparing two treatments. One treatment is pembrolizumab, enzalutamide and hormone treatment. The other is enzalutamide and hormone treatment. The trial is for men with prostate cancer that has spread.
Recruitment start: 29 July 2020
Recruitment end: 30 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Vincent Khoo
Merck Sharp & Dohme Ltd
Last reviewed: 20 Sept 2021
CRUK internal database number: 17102
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
